Patents by Inventor Stephen K. Tahir

Stephen K. Tahir has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPANION DIAGNOSTIC ASSAYS FOR CANCER THERAPY
    Publication number: 20100028889
    Abstract: Methods for identifying cancer patients eligible to receive Bcl-2 family inhibitor therapy and for monitoring patient response to Bcl-2 family inhibitor therapy comprise assessment of the expression levels of the biomarker combinations set out in TABLES 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 in a patient tissue sample. The methods of the invention allow more effective identification of patients to receive Bcl-2 family inhibitor therapy and of determination of patient response to the therapy.
    Type: Application
    Filed: June 24, 2009
    Publication date: February 4, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Mark G. Anderson, Paul E. Kroeger, Saul H. Rosenberg, Stephen K. Tahir, John A. Wass, Christin Tse, Viswanath Devanarayan
  • Companion diagnostic assays for cancer therapy
    Publication number: 20080199873
    Abstract: Methods for identifying cancer patients eligible to receive Bcl-2 family inhibitor therapy and for monitoring patient response to Bcl-2 family inhibitor therapy comprise assessment of the expression levels of the biomarker combinations set out in TABLES 1, 2, 3, 4, 5 or 6 in a patient tissue sample. The methods of the invention allow more effective identification of patients to receive Bcl-2 family inhibitor therapy and of determination of patient response to the therapy.
    Type: Application
    Filed: December 4, 2007
    Publication date: August 21, 2008
    Inventors: Mark G. Anderson, Paul E. Kroeger, Saul Howard Rosenberg, Stephen K. Tahir, Christin Tse, John A. Wass